OA3 HOW DO PRESCRIBERS ACT WHEN A PRODUCT IS WITHDRAWN FROM THE MARKET? FIRST LESSONS FROM THE COX-2 INHIBITORS PATIENTS POST ROFECOXIB STUDY (CIPRES)
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63197-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)63197-X/fulltext
Title :
OA3 HOW DO PRESCRIBERS ACT WHEN A PRODUCT IS WITHDRAWN FROM THE MARKET? FIRST LESSONS FROM THE COX-2 INHIBITORS PATIENTS POST ROFECOXIB STUDY (CIPRES)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63197-X&doi=10.1016/S1098-3015(10)63197-X
First page :
Section Title :
Open access? :
No
Section Order :
46